MA50489B1 - Selection and use of bacteria promoting melatonin production to reduce infantile colic - Google Patents

Selection and use of bacteria promoting melatonin production to reduce infantile colic

Info

Publication number
MA50489B1
MA50489B1 MA50489A MA50489A MA50489B1 MA 50489 B1 MA50489 B1 MA 50489B1 MA 50489 A MA50489 A MA 50489A MA 50489 A MA50489 A MA 50489A MA 50489 B1 MA50489 B1 MA 50489B1
Authority
MA
Morocco
Prior art keywords
selection
reduce
production
infantile colic
melatonin production
Prior art date
Application number
MA50489A
Other languages
French (fr)
Other versions
MA50489A (en
Inventor
Stefan Roos
Bo Möllstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Priority claimed from PCT/EP2019/069984 external-priority patent/WO2020020982A1/en
Publication of MA50489A publication Critical patent/MA50489A/en
Publication of MA50489B1 publication Critical patent/MA50489B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03031—Nucleotidase (3.1.3.31)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des souches bactériennes d'acide lactique qui sont capables de produire ou d'induire la production de mélatonine, destinées à être utilisées dans la production de mélatonine chez un sujet. Des souches préférées pour de telles utilisations sont capables de produire ou d'induire la production d'adénosine. Les utilisations thérapeutiques de telles souches comprennent le traitement ou la prévention de maladies associées à une déficience en mélatonine, par exemple la colique infantile. L'invention concerne également de nouvelles souches.The present invention relates to lactic acid bacterial strains which are capable of producing or inducing the production of melatonin, for use in the production of melatonin in a subject. Preferred strains for such uses are capable of producing or inducing the production of adenosine. Therapeutic uses of such strains include the treatment or prevention of diseases associated with melatonin deficiency, for example infantile colic. The invention also relates to novel strains.

MA50489A 2018-07-24 2019-07-24 Selection and use of bacteria promoting melatonin production to reduce infantile colic MA50489B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1812079.0A GB201812079D0 (en) 2018-07-24 2018-07-24 Selection method
PCT/EP2019/069984 WO2020020982A1 (en) 2018-07-24 2019-07-24 Selection and use of melatonin supporting bacteria to reduce infantile colic

Publications (2)

Publication Number Publication Date
MA50489A MA50489A (en) 2020-09-02
MA50489B1 true MA50489B1 (en) 2022-10-31

Family

ID=63364334

Family Applications (1)

Application Number Title Priority Date Filing Date
MA50489A MA50489B1 (en) 2018-07-24 2019-07-24 Selection and use of bacteria promoting melatonin production to reduce infantile colic

Country Status (2)

Country Link
GB (1) GB201812079D0 (en)
MA (1) MA50489B1 (en)

Also Published As

Publication number Publication date
GB201812079D0 (en) 2018-09-05
MA50489A (en) 2020-09-02
TW202019448A (en) 2020-06-01

Similar Documents

Publication Publication Date Title
MA53937A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MA46018A (en) GENOME EDITING ACTIVATORS
MX2021004431A (en) Novel processes.
MA55434B1 (en) Compositions comprising bacterial strains
MA47119B1 (en) Administration of protein based on bacteria with reduced virulence
MX2018009539A (en) Use of microbial communities for human and animal health.
MA31767B1 (en) ORGANIC COMPOUNDS AND USES THEREOF
MA34002B1 (en) ANTIVIRAL THERAPY
MA52492B1 (en) RIP1 INHIBITORY COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF
MA39033A1 (en) Solid forms of {[5- (3-chlorophenyl) -3-hydroxypyridine-2-carbonyl] amino} acetic acid, compositions and uses thereof
MA32226B1 (en) Compositions and their methods of preparation and use
MA35513B1 (en) Pharmaceutical compositions comprising 40 - o - (2 - hydroxy) ethyl - rapamycin
MA48486B1 (en) Proton-binding polymers for oral administration
FR3084255B1 (en) STREPTOCOCCUS THERMOPHILUS CNRZ160 STRAIN FOR THE TREATMENT AND PREVENTION OF BOWEL INFLAMMATION AND RELATED DISORDERS IN AN INDIVIDUAL
EA202092225A1 (en) CONNECTIONS AND THEIR APPLICATION
MA30485B1 (en) AMINOTHIAZOLES AND USES THEREOF
MA62935B1 (en) METHODS OF TREATMENT OR PREVENTION OF SPINAL AMYOTROPHY
MX2022000712A (en) Nlrp3 modulators.
FR3073139B1 (en) COMPOSITION IMPROVING ANIMAL WELFARE
WO2021004958A3 (en) Compositions comprising bacterial strains
EA202192047A1 (en) COMPOUNDS AND THEIR APPLICATIONS
PH12020551922A1 (en) Selection and use of melatonin supporting bacteria to reduce infantile colic
MX2023003675A (en) Hsd17b13 inhibitors and uses thereof.
MA50489B1 (en) Selection and use of bacteria promoting melatonin production to reduce infantile colic
TR200103638T2 (en) IL-8 Receptor antagonists